Stock Events

Stock Events

Integrated BioPharma 

$0.165000
1
-$0.01-2.94%Friday 20:00

Statistics

Day High
0.165
Day Low
0.165
52W High
0.42
52W Low
0.14
Volume
16,491
Avg. Volume
8,829
Mkt Cap
5.13M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Feb 10Expected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
0
0.05
0.09
0.14
Expected EPS
0
Actual EPS
N/A

Financials

-6.48%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
43.87MRevenue
-2.84MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a biopharmaceutical company that competes in the development of pharmaceuticals, similar to Integrated BioPharma's focus on nutritional and health products.
AMGEN
AMGN
Mkt Cap251.94B
Amgen is a biotech firm focusing on human therapeutics, competing in the broader biopharmaceutical market alongside Integrated BioPharma.
Biogen
BIIB
Mkt Cap37.49B
Biogen competes with Integrated BioPharma in the biopharmaceutical sector, focusing on therapies for neurological diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals is involved in the discovery, development, and commercialization of pharmaceutical products, directly competing with Integrated BioPharma's product offerings.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals is known for creating treatments for serious diseases, competing in the same biopharmaceutical space as Integrated BioPharma.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in the pharmaceuticals industry, developing products that could be in direct competition with Integrated BioPharma's health-related products.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical corporation that competes across various therapeutic areas, including those targeted by Integrated BioPharma.
Merck
MRK
Mkt Cap368.89B
Merck & Co. is a global healthcare company that develops pharmaceuticals in various areas, potentially competing with Integrated BioPharma's product lines.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson is a diversified healthcare giant that competes with Integrated BioPharma through its pharmaceutical and consumer health products.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that produces pharmaceuticals in several therapeutic areas, competing with Integrated BioPharma's offerings.

About

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Show More
CEO
Riva Sheppard
Employees
153
Country
United States
ISIN
US45811V1052

Listings

OTC Link
US
INBP

0 Comments

Share your thoughts

FAQs

What is Integrated BioPharma stock price today?▼
The current price of INBP is $0.17 USD — it has decreased by -2.94% in the past 24 hours. Watch Integrated BioPharma stock price performance more closely on the chart.
What is Integrated BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Integrated BioPharma stocks are traded under the ticker INBP.
Is Integrated BioPharma stock price growing?▼
INBP stock has fallen by -2.94% compared to the previous week, the month change is a -9.34% fall, over the last year Integrated BioPharma has showed a -46.77% decrease.
What is Integrated BioPharma market cap?▼
Today Integrated BioPharma has the market capitalization of 5.13M
What is Integrated BioPharma revenue for the last year?▼
Integrated BioPharma revenue for the last year amounts to 43.87M USD.
What is Integrated BioPharma net income for the last year?▼
INBP net income for the last year is -2.84M USD.
How many employees does Integrated BioPharma have?▼
As of November 2, 2026, the company has 153 employees.
In which sector is Integrated BioPharma located?▼
Integrated BioPharma operates in the Health & Wellness sector.
When did Integrated BioPharma complete a stock split?▼
Integrated BioPharma has not had any recent stock splits.
Where is Integrated BioPharma headquartered?▼
Integrated BioPharma is headquartered in Hillside, United States.